Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Death receptors are a subset of cell surface receptors belonging to the tumor necrosis factor receptor (TNFR) superfamily. They are characterized by an intracellular death domain (DD) and play a central role in regulating apoptosis and other cellular processes. Major members include TNFR1, Fas/CD95/APO-1, TRAILR1/DR4, TRAILR2/DR5, DR3, and DR6. Upon ligand binding, death receptors oligomerize and recruit adaptor proteins to form the death-inducing signaling complex (DISC), which activates caspases and leads to apoptosis. Death receptor activity can be modulated by decoy receptors and adaptor proteins. Dysregulation of death receptor pathways contributes to diseases such as cancer and autoimmune disorders, making them important therapeutic targets.
Induction of apoptosis via DISC formation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Death Receptor (DR).